Enzyme inhibition/inhibitors active site directed

Irreversible enzyme inhibition, also cahed enzyme inactivation (or active-site directed ineversible inhibition, because it is generally competitive with substrate), occurs when a compound blocks the enzyme activity for an extended period of time, generally via covalent bond formation. Therefore, even though some slow tight-binding inhibitors functionahy block the enzyme activity irreversibly, they are stih considered reversible... 

Information relevant to the mechanism of an enzyme-catalyzed reaction can, in general, only be obtained from irreversible inhibitors which react specifically at the active site and thereby inactivate the enzyme. As active-site-directed inhibition is treated in detail in Ref. 142 general aspects will be discussed here only briefly. In order to be suitable as an active-site-directed inhibitor, a compound must fulfil the following requirements. 

Tissue factor pathway inhibitor (TFPI) is a major physiologic inhibitor of coagulation. It is a protein that circulates in the blood associated with lipoproteins. TFPI directly inhibits factor Xa by binding to the enzyme near its active site. This factor Xa-TFPI complex then inhibits the factor Vlla-tissue factor complex. 

Active site-directed /3-lactam-derived inhibitors have a competitive component of inhibition, but once in the active site they form an acyl enzyme species which follows one or mote of the pathways outlined in Figure 1. 

Since guanine aminohydrolase catalyzes the deamination of thioguanine and 8-azaguanine thereby destroying their anti-neoplastic effects, Baker and his colleagues have prepared a series of active site directed irreversible inhibitors to block the enzyme in tumor tissue (193). The most effective inhibitor, 9-(4-methoxy phenyl)guanine, effected a 50 inhibition at 0.38 nM in the presence of 13.3 juM substrate (194). 

In the presence of an excess of the glutamine analog, DON, the enzyme is readily inactivated irreversibly (7). This substance behaves as an active-site-directed alkylating agent in a number of enzymes which utilize glutamine as substrate (3). With the use of 6-I4C-DON, the amount of inhibitor covalently bound to protein can be directly measured and, as shown in Fig. 1, this amount is linearly correlated with the extent of inhibition of catalytic activity. The simplest explanation of this behavior is that irreversible reaction of one molecule of DON with the enzyme inactivates one catalytic site, probably by combination with an essential group at that site. With this assumption the concentration of active sites in an enzyme preparation may be calculated for the... 

Active-site directed inhibitors have reactivity with the enzyme greatly enhanced over that of non-specific inhibitors thus phenacyl iodide inhibits papain 50-fold faster than iodoacetamide whereas the active-site directed inhibitor 4-toluenesulphonylamidomethyl chloromethyl ketone reacts some 650-fold faster. The enhanced rate is due to complexation of the inhibitor with the enzyme, and indicates that the inhibitor must be reacting at the active site. 

As with the other enzymes in the GPI anchor biosynthetic pathway, little is known concerning the phosphoethanolamine transferase. However, the gene responsible for the defect in phosphoethanolamine transfer in the Class F Thy-1 mutants has been cloned [89]. The 917 base pair sequence encodes for a predicted hydrophobic protein of 219 amino acids. Phosphoethanolamine transferase activity in trypanosome cell lysates is inhibited by active site serine-directed inhibitors, such as phenylmethylsulfonyl fluoride and diisopropylfluorophosphate [90]. 

Active site directed p-lactam-derived inhibitors have a competitive component of inhibition, but once in the active site they form an acyl enzyme species which follows one or more of the pathways outlined in Figure 1. Compounds that follow Route C and form a transiendy inhibited enzyme species and are subsequendy hydrolyzed to products have been termed inhibitory substrates or competitive substrates. Inhibitors that give irreversibly inactivated p-lactamase (Route A) are called suicide inactivators or irreversible inhibitors. The term progressive inhibitor has also been used. An excellent review has appeared on inhibitor interactions with p-lactamases (28). 

During irreversible inhibition, after initial binding of the inhibitor to the enzyme, covalent bonds are formed between a functional group on the enzyme and the inhibitor. This is the case, for example, for the active-site-directed inhibitors (affinity labelling). 

As previously described, irreversible enzyme inhibition is defined as time-dependent inactivation of the enzyme, which implies that the enzyme has, in some way or form, been permanently modified, because it can no longer carry out its function. This modification is the result of a covalent bond being formed with the inhibitor and some amino acid residue in the protein. Furthermore, this bond is extremely stable and, for all practical purposes, is not hydrolyzed fo give back the enzyme in its original state or structure. In most examples of irreversible inhibition, a new enzyme must be generated through gene transcription and translation for the enzyme to continue its normal catalytic action. Basically, there are two types of irreversible enzyme inhibitors, the affinity labels or active site-directed irreversible inhibitors and the mechanism-based irreversible enzyme inactivators. 

Tissues and cultured cells accumulate predominantly shikimate, rather than S-3-P, in the presence of glyphosate, and in cultured buckwheat cells shikimate was shown to accumulate in the vacuole.As neither S-3-P nor shikimate compete with glyphosate for binding sites on EPSP synthase, and as PEP does not accumulate in glyphosate-treated cells (Amrhein, unpublished), the inhibition of EPSP synthase is not overcome. This example illustrates that in order to effectively inhibit an enzyme vivo the inhibitor need not necessarily be of the tight-binding or suicide (Kcat active-site-directed irreversible) type. 

Mechanism of Inhibition, Additional tests indicated that inhibition by conqpound 1 was occurring via a suicide-like mechanism (1-4 7) Sephadex gel chromatography of the inactivated enzyme did not restore activity demonstrating irreversibility of the inhibition. The inhibition was shown to be active site-directed by co-preincubating the AChE with 1 mM of its substrate ACh and 40 iM of compound 1. The observed protection (>90%) against inactivation indicated inhibitor specificity for the active site. 

Alternate substrates are processed by an enzyme s normal catalytic pathway to form a stable covalent enzyme-inhibitor intermediate, such as an acyl-enzyme in the case of serine proteases, where the complex is essentially trapped in a potential energy well. As such, the inhibition is both time dependent and active-site directed. Theoretically, alternate substrates are reversible inhibitors, since the enzyme is essentially unchanged rather, it is suspended at a point within the catalytic process. However, in practical terms, the enzyme-inhibitor complex can be of such stability as to render the inhibition virtually irreversible. 

That the inactivation was active-site directed was also established in several ways. As mentioned above, the pA a values of k2 and k, were consistent with the pKa value of catalytic activity for a serine protease. Difference spectra of enzyme with inhibitor showed the reactive product being formed in the presence of enzyme. Rates of inhibition decreased in the presence of a known competitive inhibitor, elastatinal (Okura et al., 1975). The reactive intermediate was generated by mild alkaline hydrolysis and added to assay buffer at a concentration 25 times higher than the Ki of the ynenol lactone. Enzyme and substrate were added to the mixture, and neither inhibition nor time-dependent inactivation was observed. Therefore, inactivation was unlikely to occur by enzymatic release of the reactive intermediate followed by nonspecific alkylation outside the active site. 

In a broad sense an enzyme is specifically inhibited when its active site is blocked physically and/or chemically without significant alteration of the rest of the molecule. For this, many types of covalent inhibitors have been developed. The desired goal is chemical modification of an active site amino acid residue of the enzyme and subsequent loss of catalytic activity. The most common approach has been the synthesis of structurally and chemically reactive analogues of a substrate of the target enzyme. Such inhibitors have been referred to as active-site-directed irreversible inhibitors or affinity labels (312,313). Generally the affinity label has a reactive electrophilic substituent that can generate a stable covalent bond with an active site nucleophilic... 

Rhizobitoxine, an analogue of cystathionine produced by certain strains of Rhizobium japonicum (Owens et al., 1972), is a potent irreversible inhibitor of plant cystathionine 8-lyase both in vivo (Giovanelli et al., 1973) and in vitro. Inhibition of the purified spinach enzyme was of the active-site-directed irreversible type (Giovanelli et al., 1971), and probably involves covalent linkage of a cleavage product of rhizobitoxine to the pyridoxal phosphate prosthetic group of the enzyme. 

---